Glac Biotech Co., Ltd
Tainan City, Taiwan
Food manufacturing supply
744, Tainan City, Xinshi District, Guoji Rd, 17號4樓
About Glac Biotech Co., Ltd
"全球益生菌解決方案專家 功能益生菌領導者"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Glac Biotech Co., Ltd
During the past decade, Glac Biotech Co., Ltd conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
2002-08-01
Completed
552
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
2004-02-01
2006-02-01
Completed
67
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Glac Biotech Co., Ltd
According to Clinical.Site data, the most researched conditions in "Glac Biotech Co., Ltd" are
"Alzheimer Disease" (1 trials), "Atopic Dermatitis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Oral Health" (1 trials) and "Probiotic Metabolites" (1 trials). Many other conditions were trialed in "Glac Biotech Co., Ltd" in a lesser frequency.
Clinical Trials Intervention Types at Glac Biotech Co., Ltd
Most popular intervention types in "Glac Biotech Co., Ltd" are "Dietary Supplement" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Bifidobacterium animalis subsp. lactis CP-9" (1 trials), "Bifidobacterium longum CCFM1029" (1 trials), "Combined heat-killed probiotics (1)" (1 trials) and "Combined heat-killed probiotics (2)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Glac Biotech Co., Ltd
The vast majority of trials in "Glac Biotech Co., Ltd" are
5 trials for "All" genders.
Clinical Trials Status at Glac Biotech Co., Ltd
Currently, there are NaN active trials in "Glac Biotech Co., Ltd".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Glac Biotech Co., Ltd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Glac Biotech Co., Ltd, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".